Is there a diminishing return of prior glycaemic control?

Affiliations

¹ Department of Internal Medicine, CARIM, School of Cardiovascular Diseases, Maastricht University, Maastricht, the Netherlands; Human Epigenetics, Baker IDI Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.
² Diabetes Domain, Baker IDI Heart and Diabetes Institute, Melbourne, VIC 3004, Australia. Electronic address: mark.cooper@bakeridi.edu.au.

Comment

Nordin M J Hanssen et al. Lancet Diabetes Endocrinol. 2014 Oct.

. 2014 Oct;2(10):767-9.

doi: 10.1016/S2213-8587(14)70160-3. Epub 2014 Jul 17.

¹ Department of Internal Medicine, CARIM, School of Cardiovascular Diseases, Maastricht University, Maastricht, the Netherlands; Human Epigenetics, Baker IDI Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.
² Diabetes Domain, Baker IDI Heart and Diabetes Institute, Melbourne, VIC 3004, Australia. Electronic address: mark.cooper@bakeridi.edu.au.

No abstract available

Comment on

Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study.
DCCT/EDIC research group. DCCT/EDIC research group. Lancet Diabetes Endocrinol. 2014 Oct;2(10):793-800. doi: 10.1016/S2213-8587(14)70155-X. Epub 2014 Jul 17. Lancet Diabetes Endocrinol. 2014. PMID: 25043685 Free PMC article. Clinical Trial.